Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Conditions
Carcinoma, Non-Small-Cell Lung
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangzhou, China
Huai He Hospital of Henan University, Kaifeng, Henan, China
Henan Provincial Chest Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China
Peking University First Hospital, Beijing, China
Xuanwu Hospital, Capital Medical University, Beijing, China
Hunan Cancer Hospital, Changsha, China
Changzhou First People's Hospital, Changzhou, China
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu, China
The First Affiliated Hospital, Chongqing Medical University, Chongqing, China
The Second Affiliated Hospital of Dalian Medical University, Dalian, China
Fujian Cancer Hospital, Fuzhou, China
The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
The Second Affiliated Hospital, Zhejiang University, Hangzhou, China
Zhejiang Cancer Hospital, Hangzhou, China
Harbin Medical University Cancer Hospital, Harbin, China
Anhui Provincial Hospital, Hefei, China
Huzhou Central Hospital, Huzhou, China
Jiangmen Central Hospital, Jiangmen, China
Shandong Provincial Hospital, Jinan, China
Lanzhou University Second Hospital, Lanzhou, China
The First Affiliated Hospital of Nanchang University, Nanchang, China
Jiangsu Cancer Hospital, Nanjing, China
Jiangsu Province Hospital, Nanjing, China
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China
Affiliated Hospital of Nantong University, Nantong, China
Ningbo No.2 Hospital, Ningbo, China
Shanghai Chest Hospital, Shanghai, China
Zhongshan Hospital Fudan University, Shanghai, China
Shanghai Pulmonary Hospital, Shanghai, China
Liaoning Provincial Cancer Hospital, Shengyang, China
Hebei Medical University Fourth Hospital, Shijiazhuang, China
Shanxi Provincial Cancer Hospital, Taiyuan, China
Taizhou Hospital of Zhejiang Province, Taizhou, China
Chest disease hospital of Tianjin City, Tianjin, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China
Wuxi People's Hospital, Wuxi, China
Xi'an International Medical Center Hospital, Xi'an, China
General Hospital of Ningxia Medical University, Yinchuan, China
Affiliated Hospital of Zunyi Medical University, Zunyi, China
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche